Vertex Pharmaceuticals filed documents with the SEC detailing institutional investment oversight.

The entities involved

• Vertex Pharmaceuticals →

  American pharmaceutical company

  • Financial firms, including RBC, TD Cowen, Leerink Partners, and Morgan Stanley, raised price targets and provided coverage for Vertex Pharmaceuticals.Tue 10:23
  • CRISPR Therapeutics and Vertex Pharmaceuticals received FDA approval for their gene therapy Casgevy for sickle cell disease.Sun 12:46
• SEC →

  Slovak company

  • SoFi disclosed a transaction in a legal filing with the SEC and its stock is traded on Nasdaq.03:55
  • Apex is conducting a public offering in the United States, listing shares on Nasdaq, and filing registration statements with the SEC.02:56

Related events

• Hewlett Packard Enterprise filed required institutional investment disclosures with the SEC.Oct 6
• SEC filing tracks institutional investment activity involving association football.Oct 14
• Surgery Partners and Fifth Third Bancorp announced increased holdings in company stock, requiring filing with the SEC on September 8, 2026.Sep 9
• Belite Bio, Inc. is seeking priority review for a drug application from the FDA and disclosed stock sales via SEC filing.Aug 14
• Colgate-Palmolive Company made required institutional filings with the SEC on July 25, 2026.Jul 25